Breaking News Headlines Today | Ground News

See every side of every news story

ajmc.com image

News from ajmc.com

ajmc.com’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

ajmc.com’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about ajmc.com

Where is ajmc.com located?ajmc.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top ajmc.com News

New Menopause Drug to Target Hot Flashes without Hormones Gets FDA Approval

FDA · United States

New Menopause Drug to Target Hot Flashes without Hormones Gets FDA Approval

89% Center coverage: 46 sources

By Jacqueline Howard, CNN (CNN) — The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday. The drug, elinzanetant, is expected to be available in the United States beginning in November under the brand name Lynkuet, Bayer said. It works by blocking the brain chemicals responsible for hot flashes and night sweats –…See the Story

Scientists Discover How Leukemia Cells “Cheat Death” and Evade Treatment

Science · United States

Scientists Discover How Leukemia Cells “Cheat Death” and Evade Treatment

75% Center coverage: 4 sources

Scientists have discovered how leukemia cells outsmart a leading treatment and may have found a way to stop them. Scientists from Rutgers Health and collaborating institutions have uncovered why a widely used leukemia drug stops working for many patients and have identified a possible method to reverse that resistance. The research team found that a [...]See the Story

FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep - GSK (NYSE:GSK)

United States · United States

FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep - GSK (NYSE:GSK)

100% Center coverage: 1 sources

On Friday, the U.S. Food and Drug Administration (FDA) approved GSK Plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy. The Blenrep approval is supported by data from the pivotal DREAMM-7 phase 3 trial. Multiple myeloma is the third most common blood cancer globally and is …See the Story

Breaking News Topics Related to ajmc.com